Healthcare provider profile · identity verified

David C Evans, MD

Family Practice · WARRENTON, VA · NPI 1346299443

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	403	101
Levothyroxine Sodium	Levothyroxine Sodium	295	63
Amlodipine Besylate	Amlodipine Besylate	246	65
Lisinopril	Lisinopril	177	37
Rosuvastatin Calcium	Rosuvastatin Calcium	177	53
Sertraline Hcl	Sertraline Hcl	152	24
Losartan Potassium	Losartan Potassium	144	40
Metoprolol Succinate	Metoprolol Succinate	133	36
Pantoprazole Sodium	Pantoprazole Sodium	126	30
Metformin Hcl	Metformin Hcl	111	30
Metformin Hcl Er	Metformin Hcl	107	29
Tamsulosin Hcl	Tamsulosin Hcl	107	26
Hydrochlorothiazide	Hydrochlorothiazide	104	23
Pravastatin Sodium	Pravastatin Sodium	92	23
Furosemide	Furosemide	90	18
Omeprazole	Omeprazole	88	22
Trazodone Hcl	Trazodone Hcl	88	20
Prednisone	Prednisone	86	34
Donepezil Hcl	Donepezil Hcl	83	suppressed
Eliquis	Apixaban	82	14
Meloxicam	Meloxicam	82	15
Allopurinol	Allopurinol	77	22
Famotidine	Famotidine	77	15
Carvedilol	Carvedilol	75	23
Gabapentin	Gabapentin	74	19
Ozempic	Semaglutide	61	18
Clonazepam	Clonazepam	60	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	57	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	18
Risperidone Odt	Risperidone	55	suppressed
Ramipril	Ramipril	54	12
Benazepril Hcl	Benazepril Hcl	52	12
Duloxetine Hcl	Duloxetine Hcl	51	11
Metoprolol Tartrate	Metoprolol Tartrate	49	12
Quetiapine Fumarate	Quetiapine Fumarate	49	suppressed
Mounjaro	Tirzepatide	47	suppressed
Atenolol	Atenolol	46	suppressed
Lorazepam	Lorazepam	46	suppressed
Simvastatin	Simvastatin	46	14
Escitalopram Oxalate	Escitalopram Oxalate	42	14
Ezetimibe	Ezetimibe	42	suppressed
Synthroid	Levothyroxine Sodium	42	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	39	28
Warfarin Sodium	Warfarin Sodium	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	11
Meclizine Hcl	Meclizine Hcl	36	13
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Memantine Hcl	Memantine Hcl	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	23
Alprazolam	Alprazolam	31	12
Tramadol Hcl	Tramadol Hcl	30	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Spironolactone	Spironolactone	27	suppressed
Cefuroxime	Cefuroxime Axetil	26	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Mirtazapine	Mirtazapine	26	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Rybelsus	Semaglutide	25	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Topiramate	Topiramate	23	suppressed
Valsartan	Valsartan	23	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	15
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	19	13
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Colchicine	Colchicine	18	suppressed
Glipizide	Glipizide	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Diazepam	Diazepam	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Azithromycin	Azithromycin	16	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	14
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	14	suppressed
Finasteride	Finasteride	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Digoxin	Digoxin	12	suppressed
Felodipine Er	Felodipine	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Methenamine Mandelate	Methenamine Mandelate	12	suppressed
Modafinil	Modafinil	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Risperidone	Risperidone	12	suppressed
Tolterodine Tartrate	Tolterodine Tartrate	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Divalproex Sodium	Divalproex Sodium	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error